Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry - Michalski, F; Tittl, L; Werth, S (Thromb Haemost, 2015)
et al.